Astrocytoma, IDH-Mutant — Trials

Astrocytoma, IDH-Mutant — Trials · CancerIndex

Clinical trials

Registered studies

25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07703436	Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease	not yet recruiting	Phase 2	40	Nuvation Bio Inc.INDUSTRY	1	Sep 22, 2026	clinicaltrials
NCT07712757	Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma	not yet recruiting	Phase 3	140	Nuvation Bio Inc.INDUSTRY	0	Jul 17, 2026	clinicaltrials

Data updated 5 days agoSource updated Sep 22, 2026source: clinicaltrials